Trailing-twelve-month (TTM) revenue is $7.94 Billion with a year-over-year growth of +7.85%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,955,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $2,091,199,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $1,847,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $2,048,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $7,942,199,999 |
Current P/S: $29,772,918,960 market capitalization ÷ $7,942,199,999 TTM revenue = 3.75x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.05B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:50.746Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Industrial Technologies and Services Segment | $3.2B | $4.2B | $4.7B | $5.6B | $5.8B | $6.1B |
| Precision and Science Technologies Segment | $725M | $991M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $2.6B | $2.3B | $2.8B | $3.3B | $3.7B | $3.8B |
| Asia Pacific | $934M | $1.1B | $1.2B | $1.3B |
$7.94B
$7.94 Billion
+7.85%
vs. $7.36B a year ago (TTM)
+9.56%
5 Year compound annual growth rate
1 Year
+7.85%
3 Year
+7.15%
5 Year
+9.56%
10 Year
+13.66%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.65B | +$415.90M | +5.75% |
| 2024 | $7.24B | +$358.90M | +5.22% |
| 2023 | $6.88B | +$959.80M | +16.22% |
| 2022 | $5.92B | +$763.90M | +14.83% |
| 2021 | $5.15B | +$1.18B | +29.68% |
| 2020 |
TTM Growth
+7.85%
3-Year CAGR
+7.15%
5-Year CAGR
+9.56%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 38 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-26T00:15:50.746Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.2B |
| $1.4B |
| $1.6B |
| $1.2B |
| EMEA | $1.4B | $1.7B | $1.9B | $2.3B | $2.4B | $2.6B |
|---|
| $3.97B |
| +$1.96B |
| +96.94% |
| 2019 | $2.02B | ($672.30M) | (24.99%) |
| 2018 | $2.69B | +$314.40M | +13.24% |
| 2017 | $2.38B | +$436.00M | +22.48% |
| 2016 | $1.94B | ($187.50M) | (8.82%) |
